VBI Vaccines (VBIV)
NASDAQ:VBIV
Holding VBIV?
Track your performance easily

VBI Vaccines (VBIV) Income Statement

2,222 Followers

VBI Vaccines Income Statement

Last quarter (Q ), VBI Vaccines's total revenue was $853.00K, an increase of 191.13% from the same quarter last year. In Q, VBI Vaccines's net income was $-156.00K. See VBI Vaccines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.68M$ 8.68M$ 1.08M$ 631.00K$ 1.06M$ 2.22M
Cost of Revenue
$ 5.47M$ 12.51M--$ 9.17M$ 7.90M
Gross Profit
$ 3.21M$ -3.83M$ 1.08M$ 631.00K$ -8.11M$ -5.68M
Operating Expense
$ 48.60M$ 88.59M$ 82.90M$ 68.66M$ 35.51M$ 40.42M
Operating Income
$ -39.92M$ -79.91M$ -81.82M$ -68.03M$ -43.62M$ -46.11M
Net Non Operating Interest Income Expense
$ -6.40M$ -6.40M$ -4.01M$ -4.73M$ -2.71M$ -2.20M
Other Income Expense
$ -1.95M$ -1.95M$ 172.00K-$ 95.00K$ -6.51M
Pretax Income
$ -92.84M$ -92.84M$ -113.30M$ -69.75M$ -46.23M$ -54.81M
Tax Provision
----$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -53.85M$ -93.84M$ -113.30M$ -69.75M$ -46.23M$ -54.81M
Basic EPS
$ -6.03$ -6.03$ -13.20$ -8.10$ -0.21$ -0.46
Diluted EPS
$ -6.03$ -6.03$ -13.20$ -8.10$ -0.21$ -0.46
Basic Average Shares
$ 62.29M$ 15.57M$ 8.61M$ 8.50M$ 218.27M$ 119.45M
Diluted Average Shares
$ 62.29M$ 15.57M$ 8.61M$ 8.50M$ 218.27M$ 119.45M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 48.60M$ 88.59M$ 82.90M$ 68.66M$ 44.68M$ 48.33M
Net Income From Continuing And Discontinued Operation
$ -92.84M$ -92.84M$ -113.30M$ -69.75M$ -46.23M$ -54.81M
Normalized Income
$ -15.26M---$ -46.33M$ -48.30M
Interest Expense
----$ 3.32M$ 3.03M
EBIT
$ -85.57M$ -84.77M$ -109.30M$ -65.02M$ -42.91M$ -51.78M
EBITDA
$ -40.70M$ -82.78M$ -105.53M$ -69.86M$ -41.26M$ -50.58M
Currency in USD

VBI Vaccines Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis